TABLE 2.

PASS analysis of the selected molecules with their predicted activity.

S. No.	Drug	Pa	Pi	Activity
1	Alectinib	0.533	0.049	Neurotransmitter uptake inhibitor
		0.416	0.052	Heat shock protein 27 antagonist
		0.474	0.151	Anti-eczematic
		0.373	0.073	Chemosensitizer
		0.327	0.073	MAP3K5 inhibitor
2	Sertindole	0.802	0.017	Anti-neurotic
		0.721	0.007	Anti-depressant
		0.717	0.006	Mood disorders treatment
		0.693	0.007	Anti-psychotic
		0.438	0.051	Neurodegenerative diseases treatment
3	Radotinib	0.790	0.005	Protein kinase inhibitor
		0.745	0.029	Nootropic
		0.624	0.009	Angiogenesis inhibitor
		0.529	0.010	Alzheimer’s disease treatment
		0.460	0.043	Neurodegenerative diseases treatment
4	Ponatinib	0.560	0.014	Angiogenesis inhibitor
		0.454	0.039	Autoimmune disorders treatment
		0.476	0.079	Anti-neoplastic
		0.417	0.021	MAP3K5 inhibitor
		0.439	0.052	PDGFR kinase inhibitor
5	Droxinostat	0.467	0.005	Anti-neoplastic (sarcoma)
		0.548	0.088	Membrane integrity agonist
		0.472	0.031	AR expression inhibitor
		0.257	0.004	Histone deacetylase inhibitor
		0.337	0.105	Apoptosis agonist

Pa, probability to be active; Pi, probability to be inactive.